These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26051544)

  • 1. Cell line-dependent cytotoxicity of poly(isobutylcyanoacrylate) nanoparticles coated with chitosan and thiolated chitosan: Insights from cultured human epithelial HeLa, Caco2/TC7 and HT-29/MTX cells.
    Pradines B; Lievin-Le Moal V; Vauthier C; Ponchel G; Loiseau PM; Bouchemal K
    Int J Pharm; 2015 Aug; 491(1-2):17-20. PubMed ID: 26051544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-free chitosan coated poly(isobutylcyanoacrylate) nanoparticles are active against trichomonas vaginalis and non-toxic towards pig vaginal mucosa.
    Pradines B; Bories C; Vauthier C; Ponchel G; Loiseau PM; Bouchemal K
    Pharm Res; 2015 Apr; 32(4):1229-36. PubMed ID: 25319099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles.
    Bravo-Osuna I; Vauthier C; Farabollini A; Palmieri GF; Ponchel G
    Biomaterials; 2007 Apr; 28(13):2233-43. PubMed ID: 17261330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal permeation enhancement of docetaxel encapsulated into methyl-β-cyclodextrin/poly(isobutylcyanoacrylate) nanoparticles coated with thiolated chitosan.
    Mazzaferro S; Bouchemal K; Skanji R; Gueutin C; Chacun H; Ponchel G
    J Control Release; 2012 Sep; 162(3):568-74. PubMed ID: 22902592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific permeability modulation of intestinal paracellular pathway by chitosan-poly(isobutylcyanoacrylate) core-shell nanoparticles.
    Bravo-Osuna I; Vauthier C; Chacun H; Ponchel G
    Eur J Pharm Biopharm; 2008 Jun; 69(2):436-44. PubMed ID: 18395430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuning of shell and core characteristics of chitosan-decorated acrylic nanoparticles.
    Bravo-Osuna I; Ponchel G; Vauthier C
    Eur J Pharm Sci; 2007 Feb; 30(2):143-54. PubMed ID: 17157487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and in vitro evaluation of mucoadhesion and permeation enhancement of thiolated chitosan-pHEMA core-shell nanoparticles.
    Moghaddam FA; Atyabi F; Dinarvand R
    Nanomedicine; 2009 Jun; 5(2):208-15. PubMed ID: 19186220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucoadhesive properties of low molecular weight chitosan- or glycol chitosan- and corresponding thiomer-coated poly(isobutylcyanoacrylate) core-shell nanoparticles.
    Palazzo C; Trapani G; Ponchel G; Trapani A; Vauthier C
    Eur J Pharm Biopharm; 2017 Aug; 117():315-323. PubMed ID: 28455206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles.
    Bravo-Osuna I; Schmitz T; Bernkop-Schnürch A; Vauthier C; Ponchel G
    Int J Pharm; 2006 Jun; 316(1-2):170-5. PubMed ID: 16580797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient Peroral Delivery of Insulin via Vitamin B12 Modified Trimethyl Chitosan Nanoparticles.
    Ke Z; Guo H; Zhu X; Jin Y; Huang Y
    J Pharm Pharm Sci; 2015; 18(2):155-70. PubMed ID: 26158281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
    Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
    Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity and Genotoxicity in Human Embryonic Kidney Cells Exposed to Surface Modify Chitosan Nanoparticles Loaded with Curcumin.
    Zheng Y; Chen Y; Jin LW; Ye HY; Liu G
    AAPS PharmSciTech; 2016 Dec; 17(6):1347-1352. PubMed ID: 26718819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of chitosan thiolation and application to thiol quantification onto nanoparticle surface.
    Bravo-Osuna I; Teutonico D; Arpicco S; Vauthier C; Ponchel G
    Int J Pharm; 2007 Aug; 340(1-2):173-81. PubMed ID: 17592748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiolated nanocarriers for oral delivery of hydrophilic macromolecular drugs.
    Dünnhaupt S; Barthelmes J; Köllner S; Sakloetsakun D; Shahnaz G; Düregger A; Bernkop-Schnürch A
    Carbohydr Polym; 2015 Mar; 117():577-584. PubMed ID: 25498673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gelation and micellization behaviors of pluronic(®) F127 hydrogel containing poly(isobutylcyanoacrylate) nanoparticles specifically designed for mucosal application.
    Pradines B; Djabourov M; Vauthier C; Loiseau PM; Ponchel G; Bouchemal K
    Colloids Surf B Biointerfaces; 2015 Nov; 135():669-676. PubMed ID: 26340355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
    Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal delivery of cyclobenzaprine hydrochloride-loaded thiolated chitosan nanoparticles for pain relief.
    Patel D; Naik S; Chuttani K; Mathur R; Mishra AK; Misra A
    J Drug Target; 2013 Sep; 21(8):759-69. PubMed ID: 23879335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved transnasal transport and brain uptake of tizanidine HCl-loaded thiolated chitosan nanoparticles for alleviation of pain.
    Patel D; Naik S; Misra A
    J Pharm Sci; 2012 Feb; 101(2):690-706. PubMed ID: 22006260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutlifunctional nanoparticles prepared from arginine-modified chitosan and thiolated fucoidan for oral delivery of hydrophobic and hydrophilic drugs.
    Chen CH; Lin YS; Wu SJ; Mi FL
    Carbohydr Polym; 2018 Aug; 193():163-172. PubMed ID: 29773368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
    Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A
    Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.